SurgiQuest To Present at J.P. Morgan Healthcare Conference
MILFORD, Conn., Jan. 7, 2014 /PRNewswire/ — SurgiQuest, Inc. (“SurgiQuest”, the “Company”), a leading provider of innovative access technologies for minimally invasive surgery, today announced that it will present at the 32(nd) Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 15, 2014. Tom Dugan, President and Chief Commercialization Officer, will make a formal presentation on the Company at 8:30 a.m. Pacific Standard Time at the Westin St. Francis Hotel, Elizabethan C room.
A slide presentation will be accessible through SurgiQuest’s Events Web site at www.surgiquest.com. The slide presentation will be archived for 90 days.
SurgiQuest, Inc. is a privately held venture-backed company, founded in May 2006. The Company develops, manufactures and markets innovative access technologies for minimally invasive surgery. SurgiQuest’s patented AirSeal® System provides unprecedented access to the abdominal cavity during minimally invasive surgery (“MIS”). Unlike conventional insufflation and trocar systems, the Company’s breakthrough integrated platform assures stable pneumoperitoneum, continuously evacuates smoke and plume when energized medical devices such as electrocautery, laser or ultrasound are used, and provides valve-free access to the abdominal cavity during both laparoscopic and robotic surgical procedures. Additional information about SurgiQuest products can be found at www.surgiquest.com.
Investor Contact: Tom Dugan 203-417-3850 email@example.com
SOURCE SurgiQuest, Inc.